Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
652.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 16.00 (2.484%)
Market Cap: £219.22m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Board Appointment

19 Aug 2008 07:00

Embargoed Release: 07:00 hrs Tuesday 19 August 2008

Avingtrans Plc (`Avingtrans' or the `Group') Board Appointment and Board changes

Avingtrans Plc, the designer, manufacturer and supplier of critical components and associated services to the medical, energy, industrial and global aerospace sectors, is delighted to announce the appointment of Stephen ("Steve") McQuillan as chief executive officer. The Group believes the appointment of this highly regarded and experienced figure will bolster the strength of the management team as Avingtrans continues to exploit the excellent prospects in its respective markets going forward.

Steve McQuillan, age 47, will commence his duties as CEO from 1st October 2008. He brings extensive expertise to the Group from the engineering and technology sectors as he was previously managing director of Serco Defence Operations, a leading integrated service solutions provider to the worldwide defence and aerospace markets, from 2005 to 2008. Prior to this, Stephen was the managing director of Oxford Instruments Superconductivity Ltd, a subsidiary of Oxford Instruments plc, the designer, manufacturer and support services provider of high technology tools and systems for industry research, space, energy and healthcare sectors.

In conjunction with this appointment, Roger McDowell, who has been acting chief executive and non-executive chairman during the interim period, will revert to non-executive chairman as from 1st October 2008.

Roger McDowell commented:

"I very much welcome Stephen to the Board of Avingtrans as group chief executive; I am delighted that someone of such a high calibre with a wealth of UK and overseas experience has agreed to join the Group. Stephen has first class knowledge of and expertise in engineering, technology and knowledge transfer markets, which will be invaluable to the Group as we continue to expand our businesses."

Steve McQuillan commented:

"I am looking forward to working with the team at Avingtrans where I see significant opportunities to grow the businesses in its respective markets. The Group has strong technical and commercial capabilities and our aim will be to leverage these over the course of time."

-ENDS-

For further information, please contact:

Avingtrans plc

Roger McDowell, Non-Executive Chairman

Tel: 0115 949 9020

KBC Peel Hunt Ltd (Nominated Adviser & Broker)

Julian BluntDavid AndersonTel: 020 7418 8900Hansard Group Adam ReynoldsTel: 020 7245 1100

In accordance with paragraph (g) of Schedule 2 to the AIM Rules for Companies, the following information is provided:

Current Directorships Past Directorships over last 5 years NPL Management Limited Oxford Instruments Superconductivity Limited Airto Limited Oxford Instruments Superconductivity Holdings Limited Oxford Instruments Molecular Biotools Limited Resonance Instruments Limited

There is no further information in respect of the above appointment required to be disclosed pursuant to paragraph (g) of Schedule 2 to the AIM Rules for Companies.

vendor
Date   Source Headline
28th Mar 20083:12 pmRNSHolding(s) in Company
10th Mar 20085:30 pmRNSBoard composition
27th Feb 20087:00 amRNSInterim Results
22nd Feb 200810:52 amRNSAppointment of Director
28th Jan 20084:56 pmRNSHolding(s) in Company
25th Jan 20083:16 pmRNSHolding(s) in Company
23rd Jan 20081:01 pmRNSHolding(s) in Company
23rd Jan 20081:00 pmRNSHolding(s) in Company
16th Jan 200811:41 amPRNRe Contract
2nd Jan 20084:23 pmRNSHolding(s) in Company
20th Dec 20075:22 pmRNSDirector/PDMR Shareholding
18th Dec 20072:46 pmRNSTrading Statement
13th Nov 20073:44 pmRNSAdditional Listing
7th Nov 20074:06 pmRNSAnnual Report and Accounts
19th Oct 20073:43 pmPRNAGM Statement
11th Oct 200712:19 pmRNSHolding(s) in Company
13th Sep 20072:55 pmRNSHolding(s) in Company
13th Sep 20077:00 amPRNFinal Results
14th Aug 20072:41 pmRNSAIM Rule 26 Compliance
24th Jul 20071:18 pmRNSDirector Declaration -Amendmt
23rd Jul 20075:24 pmRNSDirector Declaration
7th Jun 200710:59 amPRNInvestment & Trading Update
1st Jun 200710:46 amRNSHolding(s) in Company
31st May 20077:00 amRNSTotal Voting Rights
17th May 20074:58 pmRNSHolding(s) in Company
10th May 20077:01 amRNSDirector/PDMR Shareholding
2nd May 20072:47 pmRNSHolding(s) in Company
2nd May 20077:10 amRNSTrading Statement
1st May 20073:14 pmRNSHolding(s) in Company
20th Apr 200710:56 amRNSHolding(s) in Company
22nd Mar 20079:49 amRNSHolding(s) in Company
22nd Mar 20079:46 amRNSHolding(s) in Company
9th Mar 200712:00 pmRNSHolding(s) in Company
7th Mar 20073:43 pmRNSHolding(s) in Company
21st Feb 20077:00 amPRNInterim Results
6th Feb 20075:20 pmRNSHolding(s) in Company
1st Feb 20077:00 amRNSChange of Adviser
4th Jan 20077:00 amPRNTrading Update
21st Dec 200612:08 pmRNSTotal Voting Rights
21st Dec 200610:14 amRNSDirector/PDMR Shareholding
12th Dec 20061:25 pmRNSHolding(s) in Company
29th Nov 20065:23 pmRNSAdditional Listing
12th Oct 20062:49 pmPRNAGM Statement
5th Oct 20063:31 pmRNSHolding(s) in Company
2nd Oct 20062:00 pmRNSAnnual Report and Accounts
22nd Sep 20069:14 amPRNCompletion of Acquisition
15th Sep 20067:00 amPRNAcquisition & Placing
14th Sep 20065:34 pmRNSDirector/PDMR Shareholding
6th Jul 20067:00 amPRNTrading Statement
20th Jun 20061:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.